Switch to:
More From Other Websites
Major Pharma Short Interest Surges May 25 2017
Biogen's Fampyra Conditional Approval Converted to Standard May 25 2017
Neupogen and Enbrel Could See Falling Revenues in 2017 May 24 2017
AbbVie to Present at the Goldman Sachs 38th Annual Global Healthcare Conference May 24 2017
AbbVie Expects Rivals To Chip Away At Its Biggest Drug Franchise May 23 2017
Regeneron, Sanofi Undercut Amgen, AbbVie In Rheumatoid Arthritis May 23 2017
The 3 Best Dividend Stocks in Arthritis Medication May 22 2017
[$$] AmerisourceBergen and AbbVie Top Barron's 500 May 20 2017
The Zacks Analyst Blog Highlights: Boeing, AbbVie, UnitedHealth, Consolidated Edison and Cisco May 19 2017
AbbVie to Present at the Jefferies 2017 Global Healthcare Conference May 19 2017
For millions of Chinese with rare diseases, some relief in sight May 18 2017
AbbVie's Humira Loses Patent in Coherus' Petitions May 18 2017
Top 4 Marijuana Stocks to Watch for 2017 May 18 2017
New Stock Research Reports for Boeing, AbbVie and UnitedHealth May 18 2017
[$$] AbbVie: It's the Pipeline, Not the Coherus Ruling May 18 2017
AbbVie Down on Humira Patent Loss: Is More Damage in Store? May 18 2017
AbbVie, Inc. breached its 50 day moving average in a Bearish Manner : ABBV-US : May 18, 2017 May 18 2017
AbbVie Loses Key Humira Patent In Battle With Small-Cap Biotech May 17 2017
AbbVie to Present Latest Clinical Study Results in Hematology and Solid Tumor Research at the 53rd... May 17 2017
Humira Ruling Is A 'Big Victory' For Coherus May 17 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK